AAAAAA

   
Results: 1-11 |
Results: 11
Preparation of drug delivery systems using supercritical fluid technology
Authors: Kompella, UB Koushik, K
Citation: Ub. Kompella et K. Koushik, Preparation of drug delivery systems using supercritical fluid technology, CR R THER, 18(2), 2001, pp. 173-199
Expression of multidrug resistance-associated protein (MRP) in human retinal pigment epithelial cells and its interaction with BAPSG, a novel aldose reductase inhibitor
Authors: Aukunuru, JV Sunkara, G Bandi, N Thoreson, WB Kompella, UB
Citation: Jv. Aukunuru et al., Expression of multidrug resistance-associated protein (MRP) in human retinal pigment epithelial cells and its interaction with BAPSG, a novel aldose reductase inhibitor, PHARM RES, 18(5), 2001, pp. 565-572
Delivery systems for penetration enhancement of peptide and protein drugs:design considerations
Authors: Kompella, UB Lee, VHL
Citation: Ub. Kompella et Vhl. Lee, Delivery systems for penetration enhancement of peptide and protein drugs:design considerations, ADV DRUG DE, 46(1-3), 2001, pp. 211-245
Budesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells
Authors: Bandi, N Kompella, UB
Citation: N. Bandi et Ub. Kompella, Budesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells, EUR J PHARM, 425(2), 2001, pp. 109-116
Simultaneous high performance liquid chromatographic analysis of acetaminophen, salicylamide, phenyltoloxamine, and related products
Authors: Aukunuru, JV Kompella, UB Betageri, GV
Citation: Jv. Aukunuru et al., Simultaneous high performance liquid chromatographic analysis of acetaminophen, salicylamide, phenyltoloxamine, and related products, J LIQ CHR R, 23(4), 2000, pp. 565-578
In-vitro hydrolysis, permeability, and ocular uptake of prodrugs of N-[4-(benzoylamino)phenylsulfonyl]glycin, a novel aldose reductase inhibitor
Authors: Sunkara, G DeRuiter, J Clark, CR Kompella, UB
Citation: G. Sunkara et al., In-vitro hydrolysis, permeability, and ocular uptake of prodrugs of N-[4-(benzoylamino)phenylsulfonyl]glycin, a novel aldose reductase inhibitor, J PHARM PHA, 52(9), 2000, pp. 1113-1122
Barriers to drug transport in ocular epithelia
Authors: Kompella, UB Lee, VHL
Citation: Ub. Kompella et Vhl. Lee, Barriers to drug transport in ocular epithelia, DRUG PHARM, 102, 2000, pp. 317-375
Ceftiofur distribution in plasma and joint fluid following regional limb injection in cattle
Authors: Navarre, CB Zhang, L Sunkara, G Duran, SH Kompella, UB
Citation: Cb. Navarre et al., Ceftiofur distribution in plasma and joint fluid following regional limb injection in cattle, J VET PHARM, 22(1), 1999, pp. 13-19
Rabbit corneal and conjunctival permeability of the novel aldose reductaseinhibitors: N-{[4-(benzoylamino)phenyl] sulphonyl} glycines and N-benzoyl-N-phenylglycines
Authors: Kompella, UB Sunkara, G Thomas, E Clark, CR Deruiter, J
Citation: Ub. Kompella et al., Rabbit corneal and conjunctival permeability of the novel aldose reductaseinhibitors: N-{[4-(benzoylamino)phenyl] sulphonyl} glycines and N-benzoyl-N-phenylglycines, J PHARM PHA, 51(8), 1999, pp. 921-927
Influence of pH and temperature on kinetics of ceftiofur degradation in aqueous solutions
Authors: Sunkara, G Navarre, CB Kompella, UB
Citation: G. Sunkara et al., Influence of pH and temperature on kinetics of ceftiofur degradation in aqueous solutions, J PHARM PHA, 51(3), 1999, pp. 249-255
Protein drug delivery
Authors: Kompella, UB
Citation: Ub. Kompella, Protein drug delivery, BIOPHARMACEUTICAL DRUG DESIGN AND DEVELOPMENT, 1999, pp. 239-273
Risultati: 1-11 |